Trade Ideas July 16, 2026 09:02 AM

Mosaic: Re-rating Opportunity as Fertilizer Tightness Meets Cheap Book Value

Upgrade to long - commodity cyclical setup with upside to $34 if regional supply tightness holds

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
MOS

Mosaic (MOS) looks materially undervalued relative to asset replacement and near-term market catalysts. The stock trades at roughly 0.62x book and an enterprise value to EBITDA of about 6.9, while fertilizer supply disruptions and a new rare-earths project create optionality. We upgrade MOS to a long trade with a clear entry, stop and target and a plan to hold into seasonal tightening and project de-risking over the next 180 trading days.

Mosaic: Re-rating Opportunity as Fertilizer Tightness Meets Cheap Book Value
MOS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • MOS trades at ~0.62x book and EV/EBITDA of 6.9x, implying asset-based upside.
  • Entry at $23.20 with a protective stop at $20.50 and a target of $34.00 over ~180 trading days.
  • Catalysts include seasonal tightening, geopolitically-driven supply disruptions, and the Uberaba rare-earths optionality.
  • Risks include weak farm economics, negative free cash flow (-$489.3M), commodity volatility, and project/regulatory execution risk.

Hook and thesis

Mosaic (MOS) is cheaper than the market realizes. At a current price of $23.20, shares trade at roughly 0.62x book value and an enterprise value to EBITDA near 6.9x. That combination - depressed share price, solid asset base, and improving supply dynamics across potash and phosphate - argues for a re-rating as commodity tightness and new project optionality play out.

We are upgrading MOS to a long trade. The plan is tactical but not speculative: buy into a cheap balance sheet, collect a meaningful dividend yield, and wait for fertilizer markets to tighten and company-specific catalysts to materialize. Entry, stop and target are laid out below with time and risk parameters.

Business overview - why investors should care

Mosaic produces concentrated phosphate and potash crop nutrients and operates three reporting segments: Phosphates, Potash, and Mosaic Fertilizantes. The business is capital intensive and levered to global agricultural demand and fertilizer commodity prices. Mosaic's products are fundamental inputs to food production; small shifts in supply, trade policy, or energy feedstock costs can ripple through margins.

Key balance-sheet and market context:

  • Market cap: about $7.37 billion.
  • Enterprise value: roughly $12.96 billion; EV/EBITDA: 6.9x.
  • Price-to-book: ~0.62x, implying the market values MOS well below net asset replacement in many scenarios.
  • Dividend: quarterly distribution of $0.22 per share and a yield in the neighborhood of 3.8%.

Why fundamentals support upside

There are three interlocking fundamental reasons to expect better performance over the next 6-9 months:

  • Structural supply risk in potash and phosphate - Global potash demand is projected to grow materially over the coming decade and recent trade disruptions have highlighted the fragility of supply chains. Research cited this year points to a multi-year growth trend in potash demand, with Asia - and China in particular - a dominant consumer. If exports remain constrained or shipping disruptions persist, North American producers with domestic logistics have pricing power.
  • Improving pricing tailwinds and seasonal demand - Mosaic already cited an expectation for market tightening in 2026 after weaker late-2025 volumes. Fertilizer markets often tighten seasonally ahead of planting cycles and inventory refills, which should favor producers with available priced volumes.
  • Optionality from industrial byproducts - Mosaic's joint development of the Uberaba rare-earths facility in Brazil expands optionality beyond fertilizers by targeting extraction of rare earth elements from phosphogypsum. While initial production is targeted for 2030, the project validates additional value streams from current assets.

Supporting numbers from the company snapshot

Recent trading and fundamentals underscore the valuation case:

Metric Value
Current price $23.20
52-week range $19.80 - $37.53
Market cap $7.37B
Enterprise value $12.96B
EV/EBITDA 6.9x
P/B 0.62x
Free cash flow (most recent) -$489.3M

Those figures show a company with tangible assets trading at a large discount to book. Even after accounting for cyclical earnings and recent negative free cash flow, EV/EBITDA below 7x is compelling for a firm with defensible market position in essential agricultural inputs.

Valuation framing

Valuation is attractive on both an asset and earnings multiple basis. The market effectively prices MOS at less than replacement value of tangible assets (P/B ~0.62x). From an earnings standpoint, trailing metrics appear stretched by a high P/E (the headline P/E is currently elevated), but that reflects depressed earnings in a cycle-low environment and near-term operational headwinds rather than permanent impairment.

EV/EBITDA around 6.9x suggests potential upside if fertilizer margins normalize or recover. A reversion toward mid-cycle multiples (10x EV/EBITDA) would imply meaningful upside to enterprise value and equity value if debt levels remain stable.

Catalysts

  • Seasonal tightening ahead of planting and inventory restocking - demand typically picks up into the spring growing season.
  • Prolonged supply disruption from geopolitical events or shipping chokepoints that raise global potash and phosphate prices.
  • Progress on the Uberaba rare-earths project (project de-risking or favorable pilot results), which would add optionality to Mosaic's asset base.
  • Any indication of improving operating leverage in Mosaic Fertilizantes or higher realized prices in potash and phosphate segments.

Trade plan (actionable)

We are initiating a long at an entry price of $23.20. Place a protective stop loss at $20.50 to limit downside if fertilizer demand proves weaker than expected. Our primary upside target is $34.00, which sits below the 52-week high of $37.53 but reflects a re-rating toward mid-cycle multiples and partial recovery in commodity prices.

Horizon and rationale: this is a position trade intended to be held through a recovery in commodity markets and project optionality updates. Expect to hold for up to long term (180 trading days), which gives room for seasonal demand, any supply shocks to work through the market, and meaningful execution or news on the Uberaba project.

Position sizing: given the cyclical nature and still-negative recent free cash flow (-$489.3M), keep position size moderate relative to portfolio - we recommend sizing such that a full stop-out represents no more than 1-2% of portfolio capital for most retail investors.

Technical context

Momentum is not hostile to this long. MOS sits above its 10-, 20- and 50-day simple moving averages and has an RSI around 59.6, suggesting room to run before it becomes overbought on a short-term basis. Short interest has been rising, with the most recent settlement showing nearly 29.7 million shares short - a modest supply of potential short-covering that could amplify upside on positive catalysts.

Risks and counterarguments

  • Weak farm economics and demand risk: Mosaic reported disappointing volumes in late 2025, with phosphate shipments down significantly. If fertilizer demand remains weak into the planting season, earnings may stay depressed and the stock could revisit lows.
  • Negative free cash flow and capital intensity: Recent free cash flow was negative (-$489.3M). Sustained negative cash flow or larger-than-expected capex for projects could pressure the balance sheet and limit buybacks/dividend support.
  • Commodity-price volatility: Fertilizer prices are cyclical and sensitive to energy prices and trade policy. A sharp decline in potash or phosphate prices would compress margins quickly.
  • Project and regulatory risk: The Uberaba rare-earths project is optionality, not guaranteed upside. It faces technical, environmental and permitting risks and initial production is targeted for 2030. Also, phosphogypsum handling and environmental remediation are ongoing industry risks that can create liabilities.
  • Valuation counterargument: The P/E is elevated in trailing snapshots because EPS is currently depressed; skeptics will argue the low P/B is justified if earnings never recover to historical norms. That is a valid point - MOS is a cyclical company, and patience is required.

Counterargument to our thesis: If global fertilizer demand remains structurally weak due to persistent low commodity prices or a prolonged slowdown in farm economics, MOS's valuation gap to book may persist or widen. A prolonged period of negative cash flow could force asset sales, dividend cuts, or a re-rating lower before any recovery - in that scenario, the trade would be poorly timed.

What would change our mind

We would downgrade this trade if we saw any of the following: (1) a sustained deterioration in crop prices and farmer economics that leads to continued volume weakness across consecutive quarters, (2) evidence that Mosaic cannot stabilize free cash flow within the next two to three quarters, (3) a material adverse regulatory development tied to phosphogypsum liabilities, or (4) a failure of regional fertilizer markets to show tightening signals when seasonality suggests they should.

Conclusion

Mosaic presents a structured, asymmetric opportunity: a cash-generating, asset-backed fertilizer producer trading at a discount to book and mid-cycle multiples, with several catalysts that can re-rate the stock. We are upgrading to a long trade with an entry at $23.20, a stop at $20.50, and a target of $34.00, and recommend holding for up to long term (180 trading days) to capture seasonal and structural upside. Keep position sizes modest and monitor volumes, cash flow, and project developments closely.

Trade specifics - entry $23.20 | stop $20.50 | target $34.00 | horizon: long term (180 trading days)

Risks

  • Prolonged weak demand from farmers could keep volumes depressed and delay any re-rating.
  • Negative free cash flow and capital intensity; sustained cash burn could force asset sales or dividend adjustments.
  • Commodity-price swings or easing of supply disruptions would compress margins and hurt earnings.
  • Project and environmental/regulatory risk around phosphogypsum handling and the Uberaba development could create liabilities or delays.

More from Trade Ideas

Buy Abivax After Obefazimod Clears the Hurdle - Upside Is Real, Risk Is Manageable Jul 16, 2026 Nvidia Pullback Trade: TSMC's Wake-Up Call Creates a Short Opportunity Jul 16, 2026 Lionsgate Appears Vulnerable to a Takeover - A Long Trade with Defined Risk Jul 16, 2026 Richardson Primed to Extend Its Rally - Energy and SiC Partnerships Point to Mid‑Term Upside Jul 16, 2026 SLB: Backing the Digital Pivot — Buy the Pullback for a 180‑Day Run Jul 16, 2026